COVID-19 vaccinations for patients with cancer: many remain unvaccinated despite having priority in the vaccine rollout.
作者信息
Body Amy, Ahern Elizabeth, Segelov Eva
机构信息
Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia.
School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
出版信息
Intern Med J. 2021 Oct;51(10):1760. doi: 10.1111/imj.15497.
Abstract
摘要
相似文献
1
COVID-19 vaccinations for patients with cancer: many remain unvaccinated despite having priority in the vaccine rollout.为癌症患者接种新冠疫苗：尽管在疫苗接种计划中享有优先权，但仍有许多患者未接种。
Intern Med J. 2021 Oct;51(10):1760. doi: 10.1111/imj.15497.
2
Early Covid-19 vaccination rollout: a commentary from England.早期新冠肺炎疫苗接种推广：来自英格兰的评论。
Isr J Health Policy Res. 2021 Feb 26;10(1):18. doi: 10.1186/s13584-021-00451-3.
3
The Legality and Ethics of Mandating COVID-19 Vaccination.强制接种 COVID-19 疫苗的合法性和道德性。
Perspect Biol Med. 2021;64(4):479-493. doi: 10.1353/pbm.2021.0037.
4
COVID-19 vaccines and cancer patients: acceptance, attitudes and safety.COVID-19 疫苗与癌症患者：接受度、态度和安全性。
J BUON. 2021 Sep-Oct;26(5):2183-2190.
5
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.全国性 BNT162b2 mRNA COVID-19 疫苗接种计划的初步影响。
Int J Infect Dis. 2021 Jul;108:116-118. doi: 10.1016/j.ijid.2021.05.021. Epub 2021 May 13.
6
Coincidence of fever following COVID-19 vaccine and endemic tropical diseases: a challenge to clinicians during the global rollout of COVID-19 vaccination.新冠疫苗接种后发热与地方性热带病偶合：新冠疫苗在全球推广期间对临床医生的挑战。
J Travel Med. 2021 Aug 27;28(6). doi: 10.1093/jtm/taab109.
7
Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals.社区层面的证据表明，SARS-CoV-2 疫苗对未接种疫苗的个体具有保护作用。
Nat Med. 2021 Aug;27(8):1367-1369. doi: 10.1038/s41591-021-01407-5. Epub 2021 Jun 10.
8
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日，加利福尼亚州洛杉矶县≥16 岁人群中，根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
9
Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.在非洲建立成功的冠状病毒病疫苗接种计划的考虑因素。
Emerg Infect Dis. 2021 Aug;27(8):2009-2016. doi: 10.3201/eid2708.203870. Epub 2021 Jun 17.
10
COVID-19 vaccination for cancer patients: Evidence, priority, and practice.癌症患者的新冠病毒疫苗接种：证据、优先级及实践
Vaccine. 2021 Aug 23;39(36):5075-5077. doi: 10.1016/j.vaccine.2021.07.063. Epub 2021 Jul 24.
引用本文的文献
1
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers.澳大利亚实体器官癌症患者对新冠疫苗的犹豫态度
Vaccines (Basel). 2022 Aug 23;10(9):1373. doi: 10.3390/vaccines10091373.
本文引用的文献
1
Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients.在接受治疗的癌症患者中，单剂新冠病毒mRNA疫苗后的免疫原性较弱。
Ann Oncol. 2021 Aug;32(8):1051-1053. doi: 10.1016/j.annonc.2021.04.020. Epub 2021 Apr 29.
2
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.癌症患者接种一剂与两剂新冠疫苗BNT162b2的安全性和免疫原性：一项前瞻性观察研究的中期分析
Lancet Oncol. 2021 Jun;22(6):765-778. doi: 10.1016/S1470-2045(21)00213-8. Epub 2021 Apr 27.
Zotero 插件